Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Christian Gerecke, Fabian Schumacher, Alide Berndzen, Thomas Homann & Burkhard Kleuser. (2020) Vitamin C in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells. Epigenetics 15:3, pages 307-322.
Read now
Read now
Ratnam S. Seelan, Partha Mukhopadhyay, M. Michele Pisano & Robert M. Greene. (2018) Effects of 5-Aza-2′-deoxycytidine (decitabine) on gene expression. Drug Metabolism Reviews 50:2, pages 193-207.
Read now
Read now
Articles from other publishers (54)
Henrik Rönnberg. 2023. Therapeutic Strategies in Veterinary Oncology. Therapeutic Strategies in Veterinary Oncology
89
110
.
Nicole S. Amato. 2023. Therapeutic Strategies in Veterinary Oncology. Therapeutic Strategies in Veterinary Oncology
69
88
.
Jialu Bian, Jinxia Zhao, Yinyu Zhao, Xu Hao, Shiyu He, Yuanyuan Li & Lin Huang. (2023)
Impact of individual factors on
DNA
methylation of drug metabolism genes: A systematic review
. Environmental and Molecular Mutagenesis 64:7, pages 401-415.
Crossref
Crossref
Chen Jie, Rumeng Li, Yajie Cheng, Zhihao Wang, Qiuji Wu & Conghua Xie. (2023) Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer. Frontiers in Immunology 14.
Crossref
Crossref
Sharath Mohan Bhat, Palla Ranga Prasad & Manjunath B. Joshi. 2023. Epigenetic Regulation of Cancer - Part A. Epigenetic Regulation of Cancer - Part A
63
96
.
Qiang Niu, Yu Liu, Yujing Zheng, Ziwei Tang, Yuna Qian, Ruogu Qi, Jianliang Shen & Ping Zhao. (2022) Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics. Acta Pharmaceutica Sinica B 12:12, pages 4458-4471.
Crossref
Crossref
Joanne S. Evans, Jamie Beaumont, Marta Braga, Nahal Masrour, Francesco Mauri, Alice Beckley, Shamus Butt, Christina S. Karali, Chris Cawthorne, Stephen Archibald, Eric O. Aboagye & Rohini Sharma. (2022) Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy. European Journal of Cancer 176, pages 110-120.
Crossref
Crossref
Alicja Pawlak, Kinga Chybicka, Ewa Zioło, Leon Strządała & Wojciech Kałas. (2022) The Contrasting Delayed Effects of Transient Exposure of Colorectal Cancer Cells to Decitabine or Azacitidine. Cancers 14:6, pages 1530.
Crossref
Crossref
Tamanash Bhattacharya, Liewei Yan, John M. Crawford, Hani Zaher, Irene L. G. Newton & Richard W. Hardy. (2022) Differential viral RNA methylation contributes to pathogen blocking in Wolbachia-colonized arthropods. PLOS Pathogens 18:3, pages e1010393.
Crossref
Crossref
Chirada Dusadeemeelap, Thira Rojasawasthien, Takuma Matsubara, Shoichiro Kokabu & William N. Addison. (2022) Inhibition of TET‐mediated DNA demethylation suppresses osteoblast differentiation. The FASEB Journal 36:2.
Crossref
Crossref
Edith Borcoman, Maud Kamal, Grégoire Marret, Celia Dupain, Zahra Castel-Ajgal & Christophe Le Tourneau. (2021) HDAC Inhibition to Prime Immune Checkpoint Inhibitors. Cancers 14:1, pages 66.
Crossref
Crossref
Suleyman Vural, Alida Palmisano, William C. Reinhold, Yves Pommier, Beverly A. Teicher & Julia Krushkal. (2021) Association of expression of epigenetic molecular factors with DNA methylation and sensitivity to chemotherapeutic agents in cancer cell lines. Clinical Epigenetics 13:1.
Crossref
Crossref
Shlomit Tamir, Shlomo Gavrielli, Chen Abitbol, Noam Tau, Ahuva Grubstein, Victoria Neiman, Lilach Yosef, Eli Atar & Alona Zer. (2021) Association between multitarget tyrosine kinase inhibitors and changes in CT appearance of submucosal fat in the gastrointestinal tract. Tumori Journal 107:5, pages 432-439.
Crossref
Crossref
Alexandra Wetzel, Bettina Scholtka, Fabian Schumacher, Harshadrai Rawel, Birte Geisendörfer & Burkhard Kleuser. (2021) Epigenetic DNA Methylation of EBI3 Modulates Human Interleukin-35 Formation via NFkB Signaling: A Promising Therapeutic Option in Ulcerative Colitis. International Journal of Molecular Sciences 22:10, pages 5329.
Crossref
Crossref
Yijia Li, Yangzhe Wu & Yi Hu. (2021) Metabolites in the Tumor Microenvironment Reprogram Functions of Immune Effector Cells Through Epigenetic Modifications. Frontiers in Immunology 12.
Crossref
Crossref
Stefanie Rauscher, Richard Greil & Roland Geisberger. (2021) Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators. Current Cancer Drug Targets 21:4, pages 353-359.
Crossref
Crossref
Lisa Pleyer, Michael Leisch, Alexandra Kourakli, Eric Padron, Jaroslaw Pawel Maciejewski, Blanca Xicoy Cirici, Jennifer Kaivers, Johanna Ungerstedt, Sonja Heibl, Peristera Patiou, Anthony Michael Hunter, Elvira Mora, Klaus Geissler, Maria Dimou, Maria-José Jimenez Lorenzo, Thomas Melchardt, Alexander Egle, Athina-Nora Viniou, Bhumika Jayantibhai Patel, Montserrat Arnan, Peter Valent, Christoforos Roubakis, Teresa Bernal del Castillo, Athanasios Galanopoulos, Marisa Calabuig Muñoz, Nicolas Bonadies, Antonio Medina de Almeida, Jaroslav Cermak, Andrés Jerez, Maria Julia Montoro, Albert Cortés, Alejandro Avendaño Pita, Bernardo Lopez Andrade, Eva Hellstroem-Lindberg, Ulrich Germing, Mikkael Aaron Sekeres, Alan Francis List, Argiris Symeonidis, Guillermo Francisco Sanz, Julian Larcher-Senn & Richard Greil. (2021) Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study. The Lancet Haematology 8:2, pages e135-e148.
Crossref
Crossref
Wen-Hsin Liu, Paulina Mrozek-Gorska, Anna-Katharina Wirth, Tobias Herold, Larissa Schwarzkopf, Dagmar Pich, Kerstin Völse, M. Camila Melo-Narváez, Michela Carlet, Wolfgang Hammerschmidt & Irmela Jeremias. (2020) Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL. Biomarker Research 8:1.
Crossref
Crossref
Sara Pepe, Emilia Scalzulli, Gioia Colafigli, Alessio Di Prima, Daniela Diverio, Marco Mancini, Roberto Latagliata, Maurizio Martelli, Robin Foà & Massimo Breccia. (2020) Predictive factors for response and survival in elderly acute myeloid leukemia patients treated with hypomethylating agents: a real-life experience. Annals of Hematology 99:10, pages 2405-2416.
Crossref
Crossref
Michael Leisch, Richard Greil & Lisa Pleyer. (2020) IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?. British Journal of Haematology 190:3, pages 314-317.
Crossref
Crossref
Pedro Blecua, Laura Martinez‐Verbo & Manel Esteller. (2020) The DNA methylation landscape of hematological malignancies: an update. Molecular Oncology 14:8, pages 1616-1639.
Crossref
Crossref
Maxime Gestin, Henrik Helmfors, Luca Falato, Nicola Lorenzon, Filip Ilias Michalakis & Ülo Langel. (2020) Effect of small molecule signaling in PepFect14 transfection. PLOS ONE 15:1, pages e0228189.
Crossref
Crossref
Masaki Suimye Morioka, Hideya Kawaji, Hiromi Nishiyori-Sueki, Mitsuyoshi Murata, Miki Kojima-Ishiyama, Piero Carninci & Masayoshi Itoh. 2020. Bioinformatics for Cancer Immunotherapy. Bioinformatics for Cancer Immunotherapy
277
301
.
Ewa M. Kosciuczuk, Aroop K. Kar, Gavin T. Blyth, Mariafausta Fischietti, Sameem Abedin, Alain A. Mina, Rebekah Siliezar, Tomasz Rzymski, Krzysztof Brzozka, Elizabeth A. Eklund, Elspeth M. Beauchamp, Frank Eckerdt, Diana Saleiro & Leonidas C. Platanias. (2019) Inhibitory effects of SEL201 in acute myeloid leukemia. Oncotarget 10:67, pages 7112-7121.
Crossref
Crossref
Ana Bela Sarmento-Ribeiro, Andreas Scorilas, Ana Cristina Gonçalves, Thomas Efferth & Ioannis P. Trougakos. (2019) The emergence of drug resistance to targeted cancer therapies: Clinical evidence. Drug Resistance Updates 47, pages 100646.
Crossref
Crossref
Anja L. Gawlitza, Johanna Speith, Jenny Rinke, Roman Sajzew, Elena K. Müller, Vivien Schäfer, Andreas Hochhaus & Thomas Ernst. (2019) 5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes. Journal of Cancer Research and Clinical Oncology 145:11, pages 2835-2843.
Crossref
Crossref
Ewa M. Michalak, Marian L. Burr, Andrew J. Bannister & Mark A. Dawson. (2019) The roles of DNA, RNA and histone methylation in ageing and cancer. Nature Reviews Molecular Cell Biology 20:10, pages 573-589.
Crossref
Crossref
Thomas Oellerich, Constanze Schneider, Dominique Thomas, Kirsten M. Knecht, Olga Buzovetsky, Lars Kaderali, Christoph Schliemann, Hanibal Bohnenberger, Linus Angenendt, Wolfgang Hartmann, Eva Wardelmann, Tamara Rothenburger, Sebastian Mohr, Sebastian Scheich, Federico Comoglio, Anne Wilke, Philipp Ströbel, Hubert Serve, Martin Michaelis, Nerea Ferreirós, Gerd Geisslinger, Yong Xiong, Oliver T. Keppler & Jindrich CinatlJr.Jr.. (2019) Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. Nature Communications 10:1.
Crossref
Crossref
C. Oing, M. A. Skowron, C. Bokemeyer & D. Nettersheim. (2019) Epigenetic treatment combinations to effectively target cisplatin‐resistant germ cell tumors: past, present, and future considerations. Andrology 7:4, pages 487-497.
Crossref
Crossref
Kamel Laribi, Delphine Bolle, Mustafa Alani, Habib Ghnaya, Anne Besançon, Jonathan Farhi, Kayane Mheidly, Nathalie Denizon & Alix Baugier de Materre. (2019) Impact of the relative dose intensity on survival of patients with high‐risk myelodysplastic syndromes treated with Azacitidine. Cancer Medicine 8:5, pages 2188-2195.
Crossref
Crossref
Eric Murillo-Rodríguez, Gloria Arankowsky-Sandoval, Jorge Aparecido Barros, Nuno Barbosa Rocha, Tetsuya Yamamoto, Sérgio Machado, Henning Budde, Diogo Telles-Correia, Diogo Monteiro, Luis Cid & André Barciela Veras. (2019) Sleep and Neurochemical Modulation by DZNep and GSK-J1: Potential Link With Histone Methylation Status. Frontiers in Neuroscience 13.
Crossref
Crossref
Kerri Becktell, Kerri Houser & Michael J. Burke. (2019) Epigenetic Therapy in a Patient With Down Syndrome and Refractory Acute Myeloid Leukemia. Journal of Pediatric Hematology/Oncology 41:1, pages e38-e40.
Crossref
Crossref
Ramón Cacabelos, Juan C. Carril, Ana Sanmartín & Pablo Cacabelos. 2019. Pharmacoepigenetics. Pharmacoepigenetics
191
424
.
Christoph Oing, Izudin Verem, Wael Mansour, Carsten Bokemeyer, Sergey Dyshlovoy & Friedemann Honecker. (2018) 5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells. International Journal of Molecular Sciences 20:1, pages 21.
Crossref
Crossref
Junya Matsushita, Kazuyuki Okamura, Kazuhiko Nakabayashi, Takehiro Suzuki, Yu Horibe, Tomoko Kawai, Toshihiro Sakurai, Satoshi Yamashita, Yoshikazu Higami, Gaku Ichihara, Kenichiro Hata & Keiko Nohara. (2018) The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes. BMC Cancer 18:1.
Crossref
Crossref
Hartmut Döhner, Anna Dolnik, Lin Tang, John F. Seymour, Mark D. Minden, Richard M. Stone, Teresa Bernal del Castillo, Haifa Kathrin Al-Ali, Valeria Santini, Paresh Vyas, C. L. Beach, Kyle J. MacBeth, Barry S. Skikne, Steve Songer, Nora Tu, Lars Bullinger & Hervé Dombret. (2018) Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care. Leukemia 32:12, pages 2546-2557.
Crossref
Crossref
Nicolas Marx, Clemens Grünwald‐Gruber, Nina Bydlinski, Heena Dhiman, Ly Ngoc Nguyen, Gerald Klanert & Nicole Borth. (2018) CRISPR‐Based Targeted Epigenetic Editing Enables Gene Expression Modulation of the Silenced Beta‐Galactoside Alpha‐2,6‐Sialyltransferase 1 in CHO Cells. Biotechnology Journal 13:10.
Crossref
Crossref
Christian Gerecke, Fabian Schumacher, Alexander Edlich, Alexandra Wetzel, Guy Yealland, Lena Katharina Neubert, Bettina Scholtka, Thomas Homann & Burkhard Kleuser. (2018)
Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor
CDKN1A
in colon cancer cells
. Oncotarget 9:67, pages 32822-32840.
Crossref
Crossref
Franziska La Meir, Tobias Boch, Daniel Nowak, Georgia Metzgeroth & Wolf-Karsten Hofmann. 2018. Geriatrische Onkologie. Geriatrische Onkologie
183
197
.
Florian Wolff, Michael Leisch, Richard Greil, Angela Risch & Lisa Pleyer. (2017) The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation. Cell Communication and Signaling 15:1.
Crossref
Crossref
Andre C. Schuh, Hartmut Döhner, Lisa Pleyer, John F. Seymour, Pierre Fenaux & Hervé Dombret. (2017) Azacitidine in adult patients with acute myeloid leukemia. Critical Reviews in Oncology/Hematology 116, pages 159-177.
Crossref
Crossref
Meng-wen Zhang, Kenji Fujiwara, Xu Che, Shu Zheng & Lei Zheng. (2017) DNA methylation in the tumor microenvironment肿瘤微环境中的甲基化调节机制. Journal of Zhejiang University-SCIENCE B 18:5, pages 365-372.
Crossref
Crossref
Antonio Almeida, Thomas Prebet, Raphael Itzykson, Fernando Ramos, Haifa Al-Ali, Jamile Shammo, Ricardo Pinto, Luca Maurillo, Jaime Wetzel, Pellegrino Musto, Arjan Van De Loosdrecht, Maria Costa, Susana Esteves, Sonja Burgstaller, Reinhard Stauder, Eva Autzinger, Alois Lang, Peter Krippl, Dietmar Geissler, Jose Falantes, Carmen Pedro, Joan Bargay, Guillermo Deben, Ana Garrido, Santiago Bonanad, Maria Diez-Campelo, Sylvain Thepot, Lionel Ades, Wolfgang Sperr, Peter Valent, Pierre Fenaux, Mikkael Sekeres, Richard Greil & Lisa Pleyer. (2017) Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study. International Journal of Molecular Sciences 18:4, pages 837.
Crossref
Crossref
Mark A. Dawson. (2017) The cancer epigenome: Concepts, challenges, and therapeutic opportunities. Science 355:6330, pages 1147-1152.
Crossref
Crossref
Chengyin Min, Nathan Moore, Jeffrey R. Shearstone, Steven N. Quayle, Pengyu Huang, John H. van Duzer, Matthew B. Jarpe, Simon S. Jones & Min Yang. (2017) Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia. PLOS ONE 12:1, pages e0169128.
Crossref
Crossref
Franziska La Meir, Tobias Boch, Daniel Nowak, Georgia Metzgeroth & Wolf-Karsten Hofmann. 2017. Geriatrische Onkologie. Geriatrische Onkologie
1
15
.
David L Marks, Rachel LO Olson & Martin E Fernandez-Zapico. (2016) Epigenetic control of the tumor microenvironment. Epigenomics 8:12, pages 1671-1687.
Crossref
Crossref
Julia Krushkal, Yingdong Zhao, Curtis Hose, Anne Monks, James H. Doroshow & Richard Simon. (2016) Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatment. Clinical Epigenetics 8:1.
Crossref
Crossref
Lisa Pleyer, Peter Valent & Richard Greil. (2016) Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?. International Journal of Molecular Sciences 17:7, pages 1009.
Crossref
Crossref
Yao-Yu Hsieh, Tsui-Chin Huang, Hsiang-Ling Lo, Jyun-Yan Jhan, Shui-Tein Chen & Pei-Ming Yang. (2016) Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine. Oncotarget 7:19, pages 27363-27378.
Crossref
Crossref
Lesley J. Scott. (2016) Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia. Drugs 76:8, pages 889-900.
Crossref
Crossref
Ching-Yu Yen, Hurng-Wern Huang, Chih-Wen Shu, Ming-Feng Hou, Shyng-Shiou F. Yuan, Hui-Ru Wang, Yung-Ting Chang, Ammad Ahmad Farooqi, Jen-Yang Tang & Hsueh-Wei Chang. (2016) DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers. Cancer Letters 373:2, pages 185-192.
Crossref
Crossref
Rosalba Camicia, Hans C. Winkler & Paul O. Hassa. (2015) Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review. Molecular Cancer 14:1.
Crossref
Crossref
Natalie S Shenker, Kirsty J Flower, Charlotte S Wilhelm-Benartzi, Wei Dai, Emma Bell, Edmund Gore, Mona El Bahrawy, Gillian Weaver, Robert Brown & James M Flanagan. (2015) Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues. BMC Cancer 15:1.
Crossref
Crossref